Dr. Roberts on the Prevalence of Liver Cancer

Lewis R. Roberts, MB, ChB, PhD
Published: Wednesday, Mar 01, 2017



Lewis R. Roberts, MB, ChB, PhD, professor of Medicine, Mayo Clinic, discusses the prevalence of hepatocellular carcinoma (HCC).

It is important to remember that of all of the major cancer types worldwide, liver cancer remains to be one of the most fatal, Roberts explains. Most patients are more likely to die within 1 year of being diagnosed compared with patients who have other types of cancers.

Additionally, in the United States, the incidence of liver cancer is rising, whereas there have been reported decreases of incidence and patient deaths in other tumor types. It is becoming a more heavily researched cancer in the United States, he adds.
SELECTED
LANGUAGE


Lewis R. Roberts, MB, ChB, PhD, professor of Medicine, Mayo Clinic, discusses the prevalence of hepatocellular carcinoma (HCC).

It is important to remember that of all of the major cancer types worldwide, liver cancer remains to be one of the most fatal, Roberts explains. Most patients are more likely to die within 1 year of being diagnosed compared with patients who have other types of cancers.

Additionally, in the United States, the incidence of liver cancer is rising, whereas there have been reported decreases of incidence and patient deaths in other tumor types. It is becoming a more heavily researched cancer in the United States, he adds.



View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Rapid Reviews in Oncology®: Practice-Changing Data in Acute Myeloid Leukemia: A Rapid Update From Atlanta OnlineDec 21, 20182.0
Community Practice Connections™: 2nd Annual European Congress on Hematology™: Focus on Lymphoid MalignanciesDec 30, 20182.0
Publication Bottom Border
Border Publication
x